6th Cytokine-Based Drug Development Summit 2025
May 15-16, 2025 | Boston, MA
6th Cytokine-Based Drug Development Summit will bring together leaders in the fields to discuss expanding the application of cytokine-based drugs for the potential treatment of Oncology, Immunology, and Inflammation disease indications.
The 6th Cytokine-Based Drug Development Summit unites top leaders from Candel, Regeneron, Sanofi, and more to drive the next era of cytokine-based immunotherapies. Discussions will tackle toxicity reduction, enhanced specificity, and multi-cytokine approaches, while exploring pro-drug, pulsed, and targeted immunomodulation. Join experts redefining success in oncology, immunology, and inflammation by bridging preclinical breakthroughs with real-world.
4th World ADC Asia Summit 2025
June 10-12, 2025 | Incheon, South Korea
4th World ADC Asia Summit 2025 will bring together leaders in the fields to showcase novel ADC technologies and optimize clinical trial and manufacturing efficiency in Asia.
The 4th World ADC Asia Summit is the premier forum for Asia’s fast-growing antibody-drug conjugate (ADC) community. With billions in investments and global partnerships surging, this event covers discovery, preclinical, clinical, and CMC advancements. Key discussions include emerging clinical data, novel ADC designs, and strategic licensing—featuring insights from AstraZeneca, Daiichi Sankyo, and top Asian biotech leaders.
4th Next Generation Gene Therapy Vectors 2025
June 11-12, 2025 | Boston, MA
The 4th Next Generation Gene Therapy Vectors meeting will bring together leaders in the fields to discuss the development of novel vectors to enable targeted gene therapy and enhance manufacturing efficiency and safety.
The 4th Next Generation Gene Therapy Vectors Summit brings together 60+ experts to explore cutting-edge advancements in capsid and payload design. Key discussions include vector safety, efficacy, and scalability, with insights on viral and non-viral delivery innovations. Join industry leaders shaping the future of predictable, cost-effective, and tissue-specific gene therapy platforms as they move towards clinical success.
Search